Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/21/18 → 04/15/24 |
Funding
- Janssen Research and Development LLC: $12,917.60
A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy & Safety of Canagliflozin in Children & Adolescents (>10 to <18 years) with Type 2 Diabetes-Mellitus
Project: Research